The second indigenous CAR-T cell therapy, Qartemi, has been approved by India's drug regulator. Qartemi is a "living drug" ...

In a first-of-its-kind unusual case, a doctor ‘transplanted’ cancer accidentally into his own body while performing surgery to remove a tumour from a 32-year-old patient who later died of ...

A research team has investigated a new combination therapy against cancer. This therapy employs systemic administration of the tissue hormone interferon-I combined with local application of Imiquimod.

A research team at the Medical University of Vienna led by Maria Sibilia has investigated a new combination therapy against cancer.

The field of cancer research is rapidly evolving, with a growing focus on the intersection of cancer immunology, gene editing, and epigenetics. This ...

Researchers found that dual “off the shelf” stem cells designed to release an oncolytic virus and immune check point inhibitor improved survival in a model of leptomeningeal brain metastasis ...

A new editorial was published in Oncoscience’s Volume 12 on January 14, 2025, titled “Pomalidomide improved immune profiles in myeloma." ...

Dr. David A Braun delved into detail on the molecular factors driving exceptional responses to immunotherapy in metastatic ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

White button mushrooms promoted antitumor activity among men with prostate cancer, according to results of an ongoing ...

Salk scientists have found that eliminating the bile acid-producing protein BAAT and supplementing with the bile acid UDCA ...

The confirmatory IGNYTE-3 trial is assessing RP1 in combination with nivolumab in patients with advanced melanoma who have progressed on anti-PD-1 and anti-CTLA-4 therapies or are ineligible for ...